Treating Extensively Drug-Resistant Acinetobacter baumannii: Considerations for Host Characteristics and Type of Infections
Anastasia Geladari, Dimitrios Kouroupis, Kyriaki Vafeidou, Vasileios Liakos, Maria Magoudi, Anastasia-Izampella Papathanasiou, Elias Iosifidis, Emmanuel Roilides, Charalampos Antachopoulos, Athina Pyrpasopoulou

TL;DR
This review discusses the challenges of treating drug-resistant Acinetobacter baumannii infections and highlights factors influencing treatment choices.
Contribution
The paper provides a comprehensive overview of treatment strategies for drug-resistant A. baumannii, emphasizing patient-specific and infection-specific considerations.
Findings
Mortality from invasive A. baumannii infections exceeds 40%.
Treatment decisions depend on patient profile, infection site, and resistance patterns.
Current and emerging antimicrobials are reviewed for their efficacy and pharmacokinetics.
Abstract
Acinetobacter baumannii has been characterized by CDC, WHO and most National Healthcare Systems worldwide as a critical nosocomial pathogen, and classified as an ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.) pathogen. Mortality of invasive infections due to A. baumannii exceeds 40%. To highlight its impact on public health, ECDC has organized a special project on national lab co-ordination to accurately detect and report carbapenem-resistant strains, to identify epidemiological factors for infection (or colonization) with carbapenem-resistant A. baumanii at clonal and sub-genomic level. This review aims to describe the history, epidemiology, and evolution of resistance of A. baumannii, and stress the caveats associated with the management of systemic infections. Available active…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntibiotic Resistance in Bacteria · Infections and bacterial resistance · Bacterial biofilms and quorum sensing
